Search for:
About Zealand
About Us
Disease Focus
History
Corporate Management
Corporate Governance
Corporate Social Responsibility
Board of Directors
Videos About Zealand
Transparency Reporting
R&D
Our Focus
Product Pipeline
Glepaglutide for SBS
Dasiglucagon for BHAP Systems
Dasiglucagon for CHI
BI 456906 GLP-1/GLU Dual Agonist
Amylin Analogue, ZP8396
In-licensing
What are Peptides?
Peptide Platform Video
Investor
Investor Relations
Corporate Presentation
Stock Information
Shareholder Portal
Financial Calendar
Financial Reports
Events
Annual General Meeting
SEC Filings
Analyst Coverage
Prospectus
Media
Zealand News
Media Inquiry
Downloads
Careers
Zealand as a Workplace
Meet Us
Positions
Personal Data in the Recruitment Process
Disclaimer: Beware of Recruitment Fraud
Contact
Zealand News
Media Inquiry
Downloads
Media Contacts
Anna Krassowska
Vice President, Investor Relations & Corporate Communications
ank@zealandpharma.com
